Mitochondrial Delivery of Doxorubicin Using MITO-Porter Kills Drug-Resistant Renal Cancer Cells via Mitochondrial Toxicity
Journal of Pharmaceutical Sciences - United States
doi 10.1016/j.xphs.2017.04.058
Full Text
Open PDFAbstract
Available in full text
Categories
Date
September 1, 2017
Authors
Publisher
Elsevier BV